Referenslitteratur
för:
Angemin |
|
| |
FÖRFATTARE
OCH TIDSKRIFT |
PUBLICERAD |
HÄMTA
PDF |
| |
|
|
|
| |
1.
Skouby SO. The rationale for a wider range of progestogens.
Climacteric. December; 3 (Suppl.2):12-20, 2000.
|
2000
|
Hämta här |
| |
2.
Schneider HP. Androgens and Antiandrogens.
Ann N Y Acad Sci.
Nov; 997:292-306, 2003.
|
2003 |
Hämta här |
| |
3.
Rubig A. Drospirenone: a new cardiovascular-active progestin with
antialdosterone and antiandrogenic properties.
Climacteric, October; 6 (Suppl. 3):49-54, 2003.
|
2003
|
Hämta här |
| |
4.
Gaspard U, Van den Brule F:
Angeliq: new hormonal therapy of the menopaus, with antialdosterone
and antiandrogenic properties.
Rev Med Liege 59(3):162-6; 2004
|
2004 |
Hämta här
|
| |
5. Kaunitz
AM:
Enhancing oral contraceptive success: the potential of new formulations.
Am J Obstet Gynecol 190(4 Suppl):23-9; 2004
|
2004 |
Hämta här
|
| |
6. Oelkers
W:
Drospirenone, a progestogen with antimineralcorticoid properties:
a short review.
Mol Cell Endocrinol 217(1-2):255-61; 2004
|
2004 |
Hämta här |
| |
7. Sitruk-Ware
RL:
Hormone therapy and the cardivascular system: the critical role of
progestins.
Climacteric 6:(Suppl 3), 21-8; 2003
|
2003 |
Hämta här
|
| |
8. Sitruk-Ware,
RL:
Pharmacological profile of progestins.
Maturitas
47(4):277-83; 2004
|
2004 |
Hämta här |
| |
|
|
|
| |